 | • レポートコード：B-GIR08C5685 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、タンパク質・抗体・核酸用デリバリー技術の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、等に区分しました。タンパク質・抗体・核酸用デリバリー技術の世界市場概観、企業動向、企業別タンパク質・抗体・核酸用デリバリー技術シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・タンパク質・抗体・核酸用デリバリー技術の市場概観 ・タンパク質・抗体・核酸用デリバリー技術の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・タンパク質・抗体・核酸用デリバリー技術の企業別販売動向、市場シェア、市場集中度、競争動向 ・タンパク質・抗体・核酸用デリバリー技術の世界市場規模 ・タンパク質・抗体・核酸用デリバリー技術の北米市場分析（アメリカ、カナダ、メキシコ等） ・タンパク質・抗体・核酸用デリバリー技術のアメリカ市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のカナダ市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のメキシコ市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・タンパク質・抗体・核酸用デリバリー技術のドイツ市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のイギリス市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のロシア市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・タンパク質・抗体・核酸用デリバリー技術の日本市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術の中国市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術の韓国市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術のインド市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術の東南アジア市場規模推移 ・タンパク質・抗体・核酸用デリバリー技術の南米市場分析（ブラジル、アルゼンチン等） ・タンパク質・抗体・核酸用デリバリー技術の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・タンパク質・抗体・核酸用デリバリー技術の種類別分析/販売量、売上、市場シェア（） ・タンパク質・抗体・核酸用デリバリー技術の用途別分析/市場規模（） ・タンパク質・抗体・核酸用デリバリー技術の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・タンパク質・抗体・核酸用デリバリー技術の販売チャネル・代理店・貿易業者・ディーラー分析 |
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
Scope of the Report:
Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neurological disorders and autoimmune diseases. And apply a variety of new technologies.
The global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market by product type and applications/end industries.
Market Segment by Companies, this report covers
Aphios
Arbutus Biopharma
Camurus
ConjuChem
InnoCore Pharmaceuticals
LATITUDE Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HEPtune® Technology
Intravail® Technology
RapidMist™
TheraKine Technology
Arestat™ Technology
DelSiTech™ Silica Matrix
ImSus® Technology
PLEX™ Technology
ENHANZE® Technology
Market Segment by Applications, can be divided into
Delivery of Protein
Delivery of Nucleic Acids
Delivery Antibody
Table of Contents
1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview
1.1 Product Overview and Scope of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
1.2 Classification of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Types
1.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Comparison by Types (2019-2024)
1.2.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Types in 2018
1.2.3 HEPtune® Technology
1.2.4 Intravail® Technology
1.2.5 RapidMist™
1.2.6 TheraKine Technology
1.2.7 Arestat™ Technology
1.2.8 DelSiTech™ Silica Matrix
1.2.9 ImSus® Technology
1.2.10 PLEX™ Technology
1.2.11 ENHANZE® Technology
1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market by Application
1.3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Delivery of Protein
1.3.3 Delivery of Nucleic Acids
1.3.4 Delivery Antibody
1.4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market by Regions
1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
1.5 Global Market Size of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids (2014-2024)
2 Company Profiles
2.1 Aphios
2.1.1 Business Overview
2.1.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
2.2 Arbutus Biopharma
2.2.1 Business Overview
2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
2.3 Camurus
2.3.1 Business Overview
2.3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
2.4 ConjuChem
2.4.1 Business Overview
2.4.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
2.5 InnoCore Pharmaceuticals
2.5.1 Business Overview
2.5.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
2.6 LATITUDE Pharmaceuticals
2.6.1 Business Overview
2.6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Competition, by Players
3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players Market Share
3.2.2 Top 10 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players Market Share
3.3 Market Competition Trend
4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions
4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Market Share by Regions
4.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
4.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
4.5 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
5 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries
5.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
5.2 USA Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
5.3 Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
5.4 Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
6 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries
6.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
6.2 Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
6.3 UK Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
6.4 France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
6.5 Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
6.6 Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries
7.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
7.2 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
7.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
7.4 Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
7.5 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
8 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries
8.1 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
8.2 Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
8.3 Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
8.4 Colombia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Countries
9.1 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
9.2 Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
9.3 UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
9.4 Egypt Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
9.5 Nigeria Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
9.6 South Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
10 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment by Type
10.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Market Share by Type (2014-2019)
10.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Type (2019-2024)
10.3 HEPtune® Technology Revenue Growth Rate (2014-2024)
10.4 Intravail® Technology Revenue Growth Rate (2014-2024)
10.5 RapidMist™ Revenue Growth Rate (2014-2024)
10.6 TheraKine Technology Revenue Growth Rate (2014-2024)
10.7 Arestat™ Technology Revenue Growth Rate (2014-2024)
10.8 DelSiTech™ Silica Matrix Revenue Growth Rate (2014-2024)
10.9 ImSus® Technology Revenue Growth Rate (2014-2024)
10.10 PLEX™ Technology Revenue Growth Rate (2014-2024)
10.11 ENHANZE® Technology Revenue Growth Rate (2014-2024)
11 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment by Application
11.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2014-2019)
11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Application (2019-2024)
11.3 Delivery of Protein Revenue Growth (2014-2019)
11.4 Delivery of Nucleic Acids Revenue Growth (2014-2019)
11.5 Delivery Antibody Revenue Growth (2014-2019)
12 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Forecast (2019-2024)
12.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Forecast (2019-2024)
12.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Regions (2019-2024)
12.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
12.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
12.6 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Picture
Table Product Specifications of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids and Revenue (Million USD) Market Split by Product Type
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Types in 2018
Figure HEPtune® Technology Picture
Figure Intravail® Technology Picture
Figure RapidMist™ Picture
Figure TheraKine Technology Picture
Figure Arestat™ Technology Picture
Figure DelSiTech™ Silica Matrix Picture
Figure ImSus® Technology Picture
Figure PLEX™ Technology Picture
Figure ENHANZE® Technology Picture
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Application (2014-2024)
Figure Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Applications in 2018
Figure Delivery of Protein Picture
Figure Delivery of Nucleic Acids Picture
Figure Delivery Antibody Picture
Table Global Market Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (2014-2024)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table Arbutus Biopharma Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table Camurus Basic Information, Manufacturing Base and Competitors
Table Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table ConjuChem Basic Information, Manufacturing Base and Competitors
Table ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table InnoCore Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table LATITUDE Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
Table LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Players (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Players (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Players in 2017
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Players in 2018
Figure Global Top 5 Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share in 2018
Figure Global Top 10 Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share in 2018
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Regions (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Regions (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Regions (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Regions in 2018
Figure North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
Table North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries in 2018
Figure USA Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Countries (2014-2019)
Figure Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries in 2018
Figure Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure UK Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries in 2018
Figure China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
Table South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries in 2018
Figure Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Colombia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Countries in 2018
Figure Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Egypt Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure Nigeria Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Figure South Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) by Type (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Type (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Type (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Type in 2018
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Forecast by Type (2019-2024)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share Forecast by Type (2019-2024)
Figure Global HEPtune® Technology Revenue Growth Rate (2014-2019)
Figure Global Intravail® Technology Revenue Growth Rate (2014-2019)
Figure Global RapidMist™ Revenue Growth Rate (2014-2019)
Figure Global TheraKine Technology Revenue Growth Rate (2014-2019)
Figure Global Arestat™ Technology Revenue Growth Rate (2014-2019)
Figure Global DelSiTech™ Silica Matrix Revenue Growth Rate (2014-2019)
Figure Global ImSus® Technology Revenue Growth Rate (2014-2019)
Figure Global PLEX™ Technology Revenue Growth Rate (2014-2019)
Figure Global ENHANZE® Technology Revenue Growth Rate (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Application (2014-2019)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Application (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Application (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Application in 2018
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Forecast by Application (2019-2024)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share Forecast by Application (2019-2024)
Figure Global Delivery of Protein Revenue Growth Rate (2014-2019)
Figure Global Delivery of Nucleic Acids Revenue Growth Rate (2014-2019)
Figure Global Delivery Antibody Revenue Growth Rate (2014-2019)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
Figure Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
Figure South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
ペプチド核酸市場：世界及び中国の市場分析・予測（～2024年） Peptide Nucleic Acid Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Peptide Nucleic Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Peptide Nucleic Acid manufac…- インスリン薬とデリバリー技術市場：世界及び中国市場分析・予測（～2024年） Insulin Drug and Delivery Technologies Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Insulin Drug and Delivery Technologies industry with a focus on the Chinese market. The report provides key statistics on the market status…
- 核酸ゲルステイン市場：世界及び中国市場分析・予測（～2024年） Nucleic Acid Gel Stains Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nucleic Acid Gel Stains industry with a focus on the Chinese market. The report provides key statistics on the market status of the Nucleic Acid Gel Stain…
- ポリクローナル抗体の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reac…
- 世界の診断用特殊抗体市場：市場規模・現状・予測 In 2018, the global Diagnostic Specialty Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Diagnostic Specialty Antibodies status, future forecast, growth opportunity, key ma…